Bear - I wonder (maybe hope) if Newsoara returning the patents for the territories and not making the milestone payment rather making an equity investment instead speaks to keeping the company clean to deal with Merck, Astellas and Pfizer. They obviously weren't unhappy with the results to that point or they wouldn't have made the equity investment.